Acute disseminated encephalitis/encephalomyelitis

G6_ADEM

acute disseminated encephalomyelitis: An encephalomyelitis characterized by inflammation located_in brain and located_in spinal cord that damages myelin. It usually occurs after viral infection, but also following vaccination, bacterial or parasitic infection.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G04.0#
  • Hospital discharge: ICD-9 3235A
  • Hospital discharge: ICD-8 32300
  • Cause of death: ICD-10 G04.0#
  • Cause of death: ICD-9 3235A
  • Cause of death: ICD-8 32300

2 out of 7 registries used, show all original rules.

66

4. Check minimum number of events

None

66

5. Include endpoints

None

66

6. Filter based on genotype QC (FinnGen only)

66

Control definitions (FinnGen only)

Control exclude
G6_NEUINFL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G04
Name in latin
Encephalitis disseminata acuta

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 676 304 364
Only index persons 537 257 280
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 21.71 24.51 18.75
Only index persons 20.47 23.38 17.79

-FinnGen-

Key figures

All Female Male
Number of individuals 66 40 26
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 25.74 24.83 27.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
58
Matched controls
578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
32300
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Encephalitis postinfectiosa
+∞
36.3
31
*
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
31.0
27
*
TAB00
NOMESCO Finland
Lumbar puncture
25.7
10.4
14
7
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
9.6
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
19.0
7.6
11
7
G40.9
ICD-10 Finland
Epilepsy, unspecified
19.7
7.0
10
6

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016018) Differential panel - Cerebral spinal fluid
7
5
15.41
4.68
1.3
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
14
7.25
4.14
1.7
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
5
13.00
3.84
1.3
1.0
—
—
—
0
0
(4027681)
6
5
13.00
3.84
1.7
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
9
8.53
3.65
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
11
6.96
3.27
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
12
6.38
3.11
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
28
176
2.03
2.00
5.6
6.1
inr
1.0
1.1
—
8
57
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
176
2.03
2.00
5.8
3.4
ng/l
20.2
25.3
0.24
18
113
(3018418) pH of Serum or Plasma
23
136
2.06
1.92
3.4
3.9
ph
7.4
7.4
—
6
29
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
12
4.41
1.86
1.0
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
30
2.89
1.79
8.1
3.9
mmol/l
25.8
24.7
—
8
30
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
18
3.56
1.79
1.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
19
3.36
1.70
1.2
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
20
3.19
1.62
1.7
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
28
2.67
1.50
1.6
2.5
—
—
—
0
0
(3019225) pH of Specimen
9
40
2.44
1.47
4.9
5.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
16
3.29
1.46
6.2
1.9
g/l
3.2
3.8
—
5
16
(42870588) Differential panel, method unspecified - Blood
25
167
1.80
1.41
8.3
6.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
23
2.76
1.40
4.8
1.7
%
88.5
93.9
—
6
23
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
70
2.07
1.35
2.1
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
24
160
1.79
1.35
2.9
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
35
2.46
1.32
1.8
6.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
188
1.74
1.31
4.8
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
18
2.92
1.31
8.2
5.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
18
2.92
1.31
3.6
36.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
22
145
1.78
1.28
5.1
2.4
u/l
220.3
245.6
0.06
22
138
(3023368) Bacteria identified in Blood by Culture
18
112
1.83
1.25
4.4
5.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
45
364
1.74
1.25
4.9
4.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
12
66
2.00
1.18
3.4
2.1
s
28.8
28.5
0.13
12
66
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
20
2.62
1.17
1.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
34
260
1.63
1.13
8.5
6.9
e9/l
1.9
1.9
0.18
29
235
(36304419) Bacteria [Presence] in Urine
22
150
1.70
1.12
4.4
2.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
35
272
1.61
1.07
4.0
3.4
estimate
0.0
0.0
—
10
48
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
109
1.75
1.07
2.8
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
22
2.37
1.05
1.2
1.5
—
326.7
—
0
12
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
22
2.37
1.05
1.4
1.9
ug/l
0.2
12.1
—
5
22
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
22
2.37
1.05
1.6
1.3
g/l
0.2
0.2
—
5
22
(3001604) Monocytes [#/volume] in Blood
33
256
1.58
1.00
8.6
6.9
e9/l
0.6
0.6
0.28
28
228
(3006315) Basophils [#/volume] in Blood
33
256
1.58
1.00
8.6
6.9
e9/l
0.0
0.0
0.12
28
228
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
51
1.88
0.99
1.7
1.6
—
—
—
0
0
(3015736) pH of Urine
29
219
1.58
0.98
2.9
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
27
201
1.58
0.97
4.4
3.3
e6/l
15.1
15.1
0.00
20
135
(3021601) Nitrite [Presence] in Urine by Test strip
34
271
1.53
0.88
5.5
4.7
estimate
0.0
0.0
—
10
49
(3035350) Ketones [Presence] in Urine by Test strip
34
271
1.53
0.88
4.0
3.4
estimate
0.0
0.0
—
10
48
(3021589) Normoblasts [#/volume] in Blood
30
234
1.52
0.85
11.2
10.3
e9/l
0.0
0.0
0.00
25
190
(3019150) Specific gravity of Urine by Refractometry
17
116
1.63
0.85
3.5
3.5
kg/l
1.0
1.0
—
8
16
(3004789) Transferrin [Mass/volume] in Serum or Plasma
10
58
1.85
0.85
2.4
2.1
g/l
2.7
2.5
—
10
52
(3022948) Iron [Moles/volume] in Serum or Plasma
11
67
1.77
0.81
2.5
2.0
umol/l
13.3
14.9
0.24
11
62
(3008898) HLA-B27 [Presence]
0
24
0.00
0.81
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
26
0.00
0.80
0.0
2.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
23
2.27
0.78
1.6
1.3
g/l
1.1
1.2
—
5
23
(3014007) Fractional oxyhemoglobin in Arterial blood
5
23
2.27
0.78
1.4
8.5
%
93.7
92.6
—
5
23
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
55
1.74
0.77
3.8
2.0
nmol/l
228.3
380.1
—
9
49
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
9
55
1.74
0.77
2.7
2.1
%
19.6
26.2
—
9
48
(3044889) 12 lead EKG panel
40
336
1.48
0.77
4.3
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
173
1.51
0.76
2.0
1.8
pmol/l
108.3
102.3
0.18
14
79
(3041096) Erythrocytes [Presence] in Urine by Automated
21
155
1.52
0.76
4.6
3.1
—
—
—
0
0
(3013512) EKG study
21
157
1.50
0.71
4.5
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
27
1.92
0.70
3.6
21.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
113
1.55
0.69
2.3
1.8
mg/l
1.5
0.9
0.41
11
90
(3026008) Bacteria identified in Urine by Culture
20
149
1.49
0.69
4.1
2.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
12
79
1.63
0.68
1.5
1.7
pmol/l
409.1
525.7
0.87
12
68
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
29
1.78
0.65
2.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
50
1.68
0.64
1.8
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
207
1.42
0.63
4.4
3.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
61
1.55
0.57
1.4
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
67
1.58
0.53
1.5
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
40
1.55
0.53
1.7
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
15
111
1.45
0.52
3.8
2.6
mmol/l
6.0
7.7
1.40
15
91
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
120
1.44
0.52
1.3
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
45
1.62
0.51
7.0
3.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
57
535
1.48
0.49
18.2
13.9
mmol/l
3.9
4.0
0.63
57
518
(3007164) IgA [Mass/volume] in Serum or Plasma
16
123
1.40
0.46
2.0
1.3
g/l
2.6
2.2
0.34
11
69
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
123
1.40
0.46
2.4
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
45
408
1.32
0.42
7.5
7.7
u/l
73.7
78.6
0.47
40
382
(3039443) Prostate specific Ag panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
15
0.00
0.42
0.0
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
35
308
1.29
0.41
8.1
12.0
e9/l
4.5
3.9
0.76
30
272
(4034850)
0
18
0.00
0.40
0.0
11.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
23
192
1.30
0.39
2.6
3.1
u/l
34.3
28.6
0.77
23
180
(3042936) Bacteria identified in Isolate by Culture
9
69
1.35
0.39
4.0
2.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
6
41
1.51
0.37
1.5
7.2
mmol/l
106.7
103.6
—
6
41
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
73
1.44
0.37
1.4
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
17
138
1.31
0.35
5.2
3.5
estimate
0.0
0.0
—
10
49
(3000492) Spirometry study
6
46
1.33
0.34
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
45
415
1.27
0.33
3.2
3.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
56
531
1.36
0.32
18.7
14.0
mmol/l
139.2
139.8
0.86
56
514
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
104
1.31
0.29
1.4
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
11
88
1.30
0.24
4.1
2.5
e6/l
0.6
0.7
—
6
48
(4035726)
5
38
1.34
0.24
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
5
38
1.34
0.24
4.6
3.3
g/l
0.2
0.2
—
5
38
(3025941) Bacteria identified in Stool by Culture
5
39
1.30
0.23
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
41
1.24
0.22
3.0
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
28
253
1.19
0.22
3.8
4.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
15
127
1.23
0.22
7.9
6.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
10
80
1.29
0.22
4.4
2.6
e6/l
1.0
2.6
—
5
41
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
65.1
—
0
12
(3014051) Protein [Presence] in Urine by Test strip
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
60
613
0.77
0.21
25.1
18.6
fl
90.2
90.5
0.15
60
603
(3012544) pH of Venous blood
6
47
1.30
0.21
2.3
3.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
60
613
0.77
0.21
25.0
18.6
pg
30.0
30.2
0.48
60
603
(3000963) Hemoglobin [Mass/volume] in Blood
60
613
0.77
0.21
25.5
18.8
g/l
135.6
137.3
0.45
60
603
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
4.5
—
11.3
—
0
13
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
0.1
—
0
6
(40768804) Tissue Pathology biopsy report
23
206
1.18
0.19
2.6
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
82
1.26
0.18
3.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
68
1.20
0.17
2.9
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
68
1.20
0.17
1.5
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
15
131
1.19
0.16
7.1
8.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
57
579
0.89
0.16
16.7
11.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
104
1.19
0.13
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
24
222
1.13
0.12
2.2
2.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
45
1.12
0.10
1.6
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
47
1.07
0.09
1.2
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
53
516
1.14
0.09
14.5
12.9
%
41.6
40.8
0.66
38
409
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
54
1.12
0.09
10.2
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
56
547
1.16
0.09
19.4
13.1
mg/l
18.2
20.0
0.23
49
405
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
58
1.04
0.08
3.7
6.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
58
1.04
0.08
6.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
127
1.13
0.08
2.9
3.2
—
—
—
0
0
(3002256) Pathology report gross observation
7
68
1.03
0.08
1.6
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
75
1.08
0.08
3.1
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
76
1.06
0.08
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
48
470
1.08
0.04
17.6
15.4
%
13.4
13.5
0.32
48
459
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
14
133
1.07
0.02
2.4
2.9
ng/l
845.3
895.4
—
9
109
(3003694) ABO and Rh group [Type] in Blood
18
174
1.05
0.00
1.7
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
28
275
1.03
0.00
5.9
7.1
umol/l
8.1
10.1
1.51
23
262
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.2
—
0.7
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
4.2
—
33.0
—
0
5
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
57.6
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
137.0
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
1.4
—
12.8
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
108.2
—
0
5
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
23.8
—
0
6
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
11.0
—
1235.5
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
6
0.00
0.00
0.0
8.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
7.7
—
180.3
—
0
6
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.2
—
765.8
—
0
6
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
54
0.92
0.00
1.8
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
3.0
—
0
8
(3000494) Fungus identified in Specimen by Culture
6
65
0.92
0.00
1.7
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_ADEM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_ADEM.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_ADEM – Acute disseminated encephalitis/encephalomyelitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data